@fordham1

Regular use of ivermectin as prophylaxis for COVID-19 led up to 92% reduction in COVID-19 mortality rate in a dose-response manner: results of a prospective observational study of a strictly controlled population of 88,012 subjects among 223,128 participants

, , , , , , , and . Research Gate, (2022)
DOI: 10.13140/RG.2.2.19170.61128

Description

Microsoft Word - Impacts of regular use of ivermectin on COVID019 outcomes. The Ivermectin Itajaí Study #2. July 2022..docx

Links and resources

Tags